The role of fenofibrate in reducing bile acid toxicity and inflammation for the treatment of chronic cholestatic liver diseases

被引：0
|
作者：
Alsuwayt, Bader [2 ]
Ghonem, Nisanne [1 ]
机构：
[1] Univ Rhode Isl, Biomed & Pharmaceut Sci, Kingston, RI 02881 USA
[2] MCPHS Univ, Pharmaceut Sci, Boston, MA USA
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
384
引用
收藏
页码：197A / 197A
页数：1
相关论文
共 50 条
  • [1] COMBINATION TREATMENT WITH URSODIOL AND FENOFIBRATE IMPROVES LIVER FUNCTION IN CHOLESTATIC LIVER DISEASES AND REDUCES THE TOXICITY OF THE BILE ACID POOL
    Ghonem, Nisanne S.
    Auclair, Adam
    Hemme, Christopher L.
    Gallucci, Gina
    Rodriguez, Randolph de la Rosa
    Assis, David N.
    Boyer, James L.
    HEPATOLOGY, 2019, 70 : 765A - 766A
  • [2] Treatment of chronic cholestatic liver diseases with ursodeoxycholic acid
    Leuschner, U
    Guldutuna, S
    Leuschner, M
    UPDATE ON HEPATOBILIARY DISEASES 1996, 1996, 90 : 136 - 146
  • [3] Bile acid abnormalities in cholestatic liver diseases
    Salen, G
    Batta, AK
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1999, 28 (01) : 173 - +
  • [4] TREATMENT OF CHOLESTATIC LIVER-DISEASES - ON THE ROLE OF URSODEOXYCHOLIC ACID
    STIEHL, A
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1992, 30 (10): : 743 - 747
  • [5] Bile acid-mediated signaling in cholestatic liver diseases
    Jing Zeng
    Jiangao Fan
    Huiping Zhou
    Cell & Bioscience, 13
  • [6] Bile acid-mediated signaling in cholestatic liver diseases
    Zeng, Jing
    Fan, Jiangao
    Zhou, Huiping
    CELL AND BIOSCIENCE, 2023, 13 (01):
  • [7] Novel bile acid therapeutics for the treatment of chronic liver diseases
    Hegade, Vinod S.
    Speight, R. Alexander
    Etherington, Rachel E.
    Jones, David E. J.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (03) : 376 - 391
  • [8] PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases
    Gallucci, Gina M.
    Hayes, Colleen M.
    Boyer, James L.
    Barbier, Olivier
    Assis, David N.
    Ghonem, Nisanne S.
    CELLS, 2024, 13 (15)
  • [9] Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases
    Yang, Tingting
    Khan, Ghulam Jilany
    Wu, Ziteng
    Wang, Xue
    Zhang, Luyong
    Jiang, Zhenzhou
    DRUG DISCOVERY TODAY, 2019, 24 (01) : 112 - 128
  • [10] Chronic cholestatic liver diseases
    Waldum, H. L.
    Bjornsson, E. S.
    Brenna, E.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (6-7) : 788 - 788
12345